We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.
- Authors
Litherland, S. A.; She, J.-X.; Schatz, D.; Fuller, K.; Hutson, A. D.; Peng, R. H.; Li, Y.; Grebe, K. M.; Whittaker, D. S.; Bahjat, K.; Hopkins, D.; Fang, Q.; Spies, P. D.; North, K.; Wasserfall, C.; Cook, R.; Dennis, M. A.; Crockett, S.; Sleasman, J.; Kocher, J.
- Abstract
Abstract: Methods: We examined monocyte prostaglandin synthase 2 (PGS2/COX2) expression in individuals at risk for or with type 1 diabetes including: (i) 58 established type 1 and 2 diabetic patients; (ii) 34 autoantibody positive (AA+) children and adults; (iii) 164 infants and young children with insulin-dependent diabetes mellitus (IDDM) susceptibility human leukocyte antigen (HLA) alleles; and (iv) 37 healthy control individuals, over a 5-yr period. Results: Established type 1 diabetic patients (1 month to 30+ yr post-disease onset) had significantly higher PGS2 expression than healthy controls; by contrast, insulin-treated type 2 diabetic patients had significantly lower PGS2 expression than healthy controls. Longitudinal studies of AA+ subjects at risk for type 1 diabetes indicated that 73% (11/15) of individuals who developed this disease during the study period expressed high levels of PGS2 prior to or after onset. We also found high level PGS2 expression in genetically at-risk infants and young children that correlated with having a first-degree relative with type 1 diabetes, but not with age, gender, or HLA genotype. In this population, high level PGS2 expression coincided with or preceded autoantibody detection in 30% (3/10) of subjects. Conclusions: These findings suggest that high level monocyte PGS2 expression, although subject to fluctuation, is present in at-risk subjects at an early age and is maintained during progression to and after type 1 diabetes onset.
- Subjects
DIABETES in children; PROSTAGLANDIN synthesis; ENZYMES; MONOCYTES
- Publication
Pediatric Diabetes, 2003, Vol 4, Issue 1, p10
- ISSN
1399-543X
- Publication type
Article
- DOI
10.1034/j.1399-5448.2003.00042.x